Growth rates may decline in next few years: Dr Reddy's
Country's second largest drug maker Dr Reddy's Laboratories today said its growth rates are likely to decline in the next few years due to expiry of many of its patents.
July 21, 2012 / 12:09 IST
Country's second largest drug maker Dr Reddy's Laboratories today said its growth rates are likely to decline in the next few years due to expiry of many of its patents.
The company's Vice–Chairman and CEO GV Prasad told the Annual General Meeting here that the European market is affected by intense price pressures in UK and Germany."The US will continue to drive the company's growth in the current year. However, growth rates will flatten as the patent expiries peak in the current year and decline in the next few years," Prasad said.Dr Reddy's Chairman K Anji Reddy, who was not present in AGM due to ill health, in his speech copy said it took 20 years for the company to register USD 1 billion revenues, whereas it took just five years to cross USD 2 billion
turnover in FY2011-12. Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
